BioMed Dropped $625M On A Big Boulder Bet. Here's How Leasing Is Looking
The $625M deal for Flatiron was the biggest in a bevy of market signals suggesting Boulder was poised to see significant life sciences growth. In June 2023, BioMed President of West Coast Markets Jon Bergschneider said the company would double the ...